Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

Abstract Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This study aimed to determine the modulatory effect of DPP-4i on brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT...

Full description

Bibliographic Details
Main Authors: Liying Mu, Zhuo Wang, Jinmei Ren, Xiaowei Xiong, Zening Jin, Xin Liu
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Dipeptidyl peptidase-4 inhibitors
BNP
NT-pro-BNP
Type 2 diabetes mellitus
Randomized controlled trials
Online Access:https://doi.org/10.1186/s13098-022-00797-x

Internet

https://doi.org/10.1186/s13098-022-00797-x

Similar Items